Free Trial

Ascend Wellness (OTC:AAWH) Stock Price Up 32.7% - Here's What Happened

Ascend Wellness logo with Medical background

Key Points

  • Ascend Wellness Holdings, Inc. saw its share price surge by 32.7%, reaching a last traded price of $0.69, significantly above its previous close of $0.52.
  • Trading volume increased to 889,469 shares, marking a 617% rise from the average session volume of 123,972 shares.
  • The company's market capitalization stands at $141.06 million, with a price-to-earnings ratio of -1.68 and a debt-to-equity ratio of 2.61.
  • Five stocks to consider instead of Ascend Wellness.

Shares of Ascend Wellness Holdings, Inc. (OTC:AAWH - Get Free Report) rose 32.7% on Monday . The stock traded as high as $0.70 and last traded at $0.69. Approximately 889,469 shares were traded during trading, an increase of 617% from the average daily volume of 123,972 shares. The stock had previously closed at $0.52.

Wall Street Analysts Forecast Growth

Separately, Zacks Research upgraded shares of Ascend Wellness to a "strong sell" rating in a research note on Tuesday.

Check Out Our Latest Analysis on AAWH

Ascend Wellness Price Performance

The company has a debt-to-equity ratio of 2.61, a current ratio of 1.47 and a quick ratio of 0.80. The stock has a market cap of $134.85 million, a PE ratio of -1.61 and a beta of 1.04. The firm's 50 day moving average price is $0.38 and its two-hundred day moving average price is $0.36.

About Ascend Wellness

(Get Free Report)

Ascend Wellness Holdings, Inc engages in the cultivation, manufacture, and distribution of cannabis consumer packaged goods in the United States. The company offers flower, pre-rolls, concentrates, vapes, edibles, tinctures, and other cannabis-related products under the Common Goods, SimplyHerb, Ozone, Ozone Reserve, Royale, Tunnel Vision, Miss Grass, Lowell Smokes, Edie Parker, 1906, and AiroPro brands.

Read More

Should You Invest $1,000 in Ascend Wellness Right Now?

Before you consider Ascend Wellness, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Ascend Wellness wasn't on the list.

While Ascend Wellness currently has a Sell rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

5G Stocks: The Path Forward is Profitable Cover

Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Markets Are Sliding: Where to Find Opportunity
5 Hot Stocks to Buy Now: September’s Top Picks With Major Momentum
$15 Billion for Cybersecurity: The Government’s Next Big Push

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines